(Q28744391)

English

Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice

scientific article (publication date: 2011)

In more languages

Statements

scholarly article

0 references

Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice (English)

0 references

0 references

0 references

0 references

11

object named as

Chuan Qin

0 references

6

object named as

Linlin Bao

0 references

7

object named as

Wei Deng

0 references

author name string

Shu Meng

1

0 references

Zhonghua Liu

2

0 references

Lili Xu

3

0 references

Li Li

4

0 references

Shan Mei

5

0 references

Lina Li

8

0 references

Rongyue Lei

9

0 references

Liangzhi Xie

10

0 references

Linqi Zhang

12

0 references

language of work or name

0 references

publication date

2011

0 references

0 references

6

0 references

5

0 references

e19863

0 references

copyright license

Creative Commons Attribution 4.0 International

20 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

16 March 2017

Mechanisms of histamine release by compound 48-80

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

16 March 2017

Strategies for mitigating an influenza pandemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

7 April 2017

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

7 April 2017

A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Mast cell-orchestrated immunity to pathogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Pandemic influenza A(H1N1) 2009 vaccines in the European Union.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Update on influenza A (H1N1) 2009 monovalent vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Mast cell activators: a new class of highly effective vaccine adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Mast cells in the development of adaptive immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Cold-adapted, live attenuated influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Compound 48/80: a potent histamine liberator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Cytological and pharmacological observations on the release of histamine by mast cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Mast cell cytokine and chemokine responses to bacterial and viral infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

The role of Th1/Th2 polarization in mucosal immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Regulation of antibody responses via antibodies, complement, and Fc receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

B cell response to fresh and effector T helper cells. Role of cognate T-B interaction and the cytokines IL-2, IL-4, and IL-6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

3 June 2018

Historical perspective--Emergence of influenza A (H1N1) viruses.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

Swine flu outbreak. China first to vaccinate against novel H1N1 virus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

A shot in the arm for mast cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

Caprine herpesvirus 1 vaccine with the LTK63 mutant as a mucosal adjuvant induces strong protection against genital infection in goats.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019863

21 January 2018

Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098841

27 November 2018

Older age and a reduced likelihood of 2009 H1N1 virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21625486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0019863

0 references

2011PLoSO...619863M

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28744391&oldid=1869309746"